![Info(Icon)](data/milestone/icon/1701930435634549097.png)
Info
04.24
The decision of the AMS BioteQ Board of Directors to establish a branch office in Tokyo, Japan and appoint a representative for the branch office.
![Info(Icon)](data/milestone/icon/1701930435634549097.png)
Info
04.24
Announcement of the Board Resolution of AMS BioteQ Regarding the Convening of the 113th Annual Shareholders' Meeting
![Info(Icon)](data/milestone/icon/1701930435634549097.png)
Info
04.24
The board of directors of AMS BioteQ has resolved to issue common shares by way of a private placement.
![Info(Icon)](data/milestone/icon/1701930435634549097.png)
Info
04.17
AMS BioteQ was invited to exhibit at the inaugural Japan Pharmaceutical Exhibition.
![Pat.(Icon)](data/milestone/icon/1701930421341900268.png)
Pat.
03.25
"Artificial Dressing and Its Application for Promoting Wound Healing" "patent approved by the United States Patent and Trademark Office."
![Info(Icon)](data/milestone/icon/1701930435634549097.png)
Info
03.22
Signed a memorandum of understanding (MOU) on industry-academic collaboration with the School of Pharmacy, Kaohsiung Medical University, to enhance industry-academic exchanges.
![Fund(Icon)](data/milestone/icon/1701930447143681651.png)
Fund
01.31
The capital increase case for the year 112, with a fund of 75 million NTD, has been fully subscribed, and the capital increase base date is set on 1st February.
![Pat.(Icon)](data/milestone/icon/1701930421341900268.png)
Pat.
01.18
"Artificial Dressing and Its Application for Promoting Wound Healing" has successfully obtained approval for a new invention patent in Taiwan.
![Pat.(Icon)](data/milestone/icon/1701930421341900268.png)
Pat.
01.11
SIPSIP™ Foam, the AMS BioteQ wound dressing, has successfully obtained FDA registration.